KIRYAT SHEMONA, ISRAEL – June 9, 2020 – MigVax Corp., an Israeli company developing a vaccine for COVID-19 (MigVax-101), today announced the appointment of Eyal Desheh as chairman of its board of directors.
Read more here.
[PRESS RELEASE] MigVax Appoints Eyal Desheh, Former Teva, Check Point Executive, as Chairman
![[PRESS RELEASE] MigVax Appoints Eyal Desheh, Former Teva, Check Point Executive, as Chairman](https://blog.ourcrowd.com/wp-content/uploads/2017/07/press_release_image.jpg)
